Key facts
- Coologics’s last known valuation is $7.5M (Apr 2025).
- Notable investors include Dream Ventures, Prevail Private Capital, Oakwood Circle Ventures, Illini Angels, Bold Ventures (Buffalo) — 6 tracked in total.
- 1 investment vehicle was formed to buy Coologics shares in the last 12 months, per SEC Form D filings.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Coologics
- ·The full record, as it builds
Funding rounds
No funding rounds for Coologics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Secondary demand: investment vehicles
from SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy Coologics shares. Most recent filing Nov 2025. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.
About Coologics
Developer of medical devices designed for the treatment of vaginal infections. The company's device addresses multiple mechanisms of action, including physical and mechanical interactions with the vaginal wall, time-controlled cooling that treats the infection, stops symptoms, enabling individuals suffering from recurrent vaginal infections and pregnant women to experience immediate relief and a safer, innovative alternative to traditional, often ineffective, antibiotic treatments.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2019
- Employees
- 7
- Website
- vlisse.com/
- Ownership
- Privately Held (backing)
Coologics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Coologics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Coologics in its N-PORT filings yet. We sweep new filings monthly.